Company profile
Resolys Bio company profile
Resolys Bio is a clinical-stage biotechnology company that develops therapeutic agents for acute and chronic disorders. It focuses on traumatic brain injury (TBI) and chronic tissue disorders such as joint hypermobility syndromes (JHS), lupus, rheumatoid arthritis, and fibromyalgia to help clinicians treat patients with drug development programs.
Business identity
- Website
- https://resolysbio.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $0+
- Founded
- 2016-01-01
Headquarters
- Headquarters
- Delanson, New York, United States
- Country code
- US
- Continent
- North America